Faculty – 16th Clinical Performance Metrics & Analytics Summit


Priya Chaturvedi, Ph.D.
Executive Director, Quality Assurance-Head Vaccines and ID, MERCK

view speaker profile

Priya Chaturvedi is the MRL Quality Assurance-Therapeutic Area (TA) Head for Infectious Diseases and Vaccines. In addition to her TA role, she has responsibility for Quality Assurance in Asia Pacific region. She joined Merck Pharmaceuticals in 2016. Prior to that, she was at Pfizer Pharmaceutical where most recently she was the Business Unit Quality Oversight Lead, responsible for compliance and quality oversight of medical affairs activities, and the clinical affairs portfolio. Prior to that, she was the Director of Compliance and Oversight and had responsibility for quality oversight of a large portfolio of clinical studies. Prior to joining Pfizer in 2010, Priya spent 12 years at GSK in different clinical, project management and discovery roles.

She received her doctorate from Temple University, School of Medicine, PA.


Tim Koch
Global Head of Clinical Analytics, NOVARTIS PHARMACEUTICALS CORPORATION

view speaker profile

Tim Koch has spent the last 16 years working in Big Pharma including time at Johnson & Johnson, GlaxoSmithKline, and Novartis, with prior experience in the Financial Services Industry and the Hospital Setting. He is a Lean Six Sigma Black Belt who’s deepest passion is Analytics and Metrics but has a broad range of experience from Finance to IT to Quality Assurance to Resource & Risk Management. He is known as a domain expert in Clinical Trial Optimization via Data and Technology, supporting the operational delivery of thousands of Trials from feasibility/site selection to recruitment planning/tracking to instream monitoring, resource management and risk evaluation to leading health authority inspections. Tim has been an innovative pioneer, infusing an evidence-based analytical culture in countless areas of the business, building multiple Analytics units from the ground up and launching >30 industry-first IT platforms to >20,000 users in Drug Development. He currently leads a Clinical Analytics function which spans 3 countries supporting Trial Management, Trial Monitoring, Data Operations, Vendor Management and Report Writing. His team currently oversee 25 applications, build advanced analytics, reports, and visualizations tools, centrally govern KPI reporting and deliver competitive intelligence and benchmarking.


Faye O’Brien
Director, Performance and Metrics, ASTRAZENECA


Jonathan Rowe, Ph.D., M.S., M.A.
Executive Director, Head of Clinical Development Quality Performance and Risk Management, PFIZER

view speaker profile

Jonathan Rowe has 20 years of experience supporting pharmaceutical companies in the development of medical therapies from the clinical, operational and business perspectives. Currently, Jonathan holds the position of Executive Director, Head of Clinical Development Quality Performance and Risk Management at Pfizer, where his responsibilities include monitoring, modeling and predicting the Pfizer GCP Quality Management System, leading the analysis of Pfizer’s Clinical Trial Quality Performance and ensuring clinical trial quality risk management is built into all trials. At Pfizer he has held a number of roles including Clinical Director, with responsibility for the Phase IIIb and IV Lipitor program; Director, Intellectual Property Strategy Management; and Senior Director of Process and Performance. Jonathan spent a number of years in “small pharma” as the Head of Intellectual Property and Portfolio Strategy for Amarin and Dignity Sciences. Jonathan earned his Ph.D. and M.S. at the Albert Einstein College of Medicine and his M.A. from Binghamton University.